RxDoctor Payments Data

Charles Nutting, DO

Vascular & Interventional Radiology · Greenwood Village, CONPI 1063459691

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (57.6%), consulting fees and other — rather than concentrated in one kind of arrangement. Medtronic accounts for 67.2% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2020 at $686,288 and has fallen 94.7% since, to $36,484 in 2025. Among vascular & interventional radiology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,087,352in general payments, 2019–2025

Across 327 payments — averaging $3325.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$730K
  • GE HealthCare$87K
  • Siemens Medical Solutions USA, Inc.$81K
  • Sirtex Medical Inc$58K
  • Merit Medical Systems Inc$48K
  • Angiodynamics, Inc.$40K
  • plus $43K from 23 others
$20,037in research payments, 2019–2025

Across 5 payments — averaging $4007.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Instylla, Inc.$14K
  • Merit Medical Systems Inc$6K

What the payments were for

  • Royalty or licence$625,87858%
  • Consulting fees$190,26117%
  • Speaking & faculty fees$99,8409%
  • Travel & lodging$19,0732%
  • Food & beverage$8,8151%
  • Education$24,5182%
  • Other$118,96711%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,087,352 in reported general payments places this provider in the 95th percentile of 105 vascular & interventional radiology providers in Colorado.

See all vascular & interventional radiology providers in Colorado

Medicare billing

Part B allowed, 2024
$662,844
Medicare patients
131
Services billed
4,778

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst66$536
Methylprednisolone81$497
Oxybutynin Chloride68$296
Tamsulosin Hcl30$266
Oxycodone Hcl58$209
Ondansetron Hcl14$71

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Greenwood Village

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →